Anti-Obesity Prescription Drugs Market

Anti-Obesity Prescription Drugs Market : Segmental Highlights and Table of Content ( 2017-2026)
Anti-Obesity Prescription Drugs Market: Adult Age Group to Generate Significant Revenues
Increasing prevalence of obesity has led to an upsurge in demand for anti-obesity prescription drugs
globally. In addition, increasing level of chronic stress is also expected to impact the global market
growth of anti-obesity prescription drugs positively. Transparency Market Research states that the
global anti-obesity prescription drugs market is projected to reflect a CAGR of 4.8% over the
forecast period, 2017-2026.
As patients of high blood and sugar levels are more prone to the risk of obesity, doctors are
increasingly prescribing liraglutide medicines. Based on the drug class, the liraglutide segment is
projected to generate significant revenues, representing more than US$ 100 Mn by 2026-end. In
contrary to this, the bupropion and naltrexone drug class segment is projected to reflect a significant
CAGR through 2022. In terms of revenue, the adult age group segment is projected to account for
more than US$ 100 Mn by 2017-end. This segment is projected to witness a robust CAGR in the
global market of anti-obesity prescription drugs during the forecast period. By 2026-end, the
hospital pharmacies distribution channel segment will continue to witness the fastest growth,
accounting for more than US$ 100 Mn.
Request A Sample [email protected] https://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=34835
Summary of Table of Content :
1. Global Anti-Obesity Prescription Drugs Market - Executive Summary
2. Global Anti-Obesity Prescription Drugs Market Overview
3. Global Anti-Obesity Prescription Drugs Market Analysis and Forecast 2012-2026
3.1. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Drug Class, 2012-202
3.2. Global Anti-Obesity Prescription Drugs Market Size and Forecast By Age Group, 2012-2026
4. North America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
5. Latin America Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
6. Europe Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
7. Japan Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
8. APEJ Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
9. MEA Anti-Obesity Prescription Drugs Market Size and Forecast, 2012-2026
10. Global Anti-Obesity Prescription Drugs Market Company Share, Competition Landscape and
11. Research Methodology
12. Secondary and Primary Sources
13. Assumptions and Acronyms
14. Disclaimer
Request to Browse Full Table of Content, figure and Tables @
https://www.transparencymarketresearch.com/report-toc/34835
Or
Get Full [email protected] https://www.transparencymarketresearch.com/checkout.php?
rep_id=34835&ltype=S